The Business Times
business-time-50

Cardinal to buy private generic drug distributor for US$1.12 billion

google-preferred-sourceAdd BT as a preferred source
Published Fri, Jun 5, 2015 · 11:26 AM

DeeperDive is a beta AI feature. Refer to full articles for the facts.

[BENGALURU] Cardinal Health Inc said it would buy privately held drug distributor Harvard Drug Group for US$1.12 billion.

Cardinal said it expects the deal to add more than 15 US cents per share to adjusted earnings from continuing operations in 2016 and 17 US cents per share in 2017.

REUTERS

HealthcarePharmaceuticals

Share with us your feedback on BT's products and services

Feedback

TRENDING NOW

Andrew Lee, chairman of OCBC (right), and group chief executive Tan Teck Long speaking at Thursday's (Apr 16) AGM.

Shelving S$5 billion office redevelopment plan proved ‘wise’ as geopolitical risks mount: OCBC chairman

HSBC has said that it’s carrying out targeted strategic reviews of its retail businesses across Australia, Indonesia and Egypt, but no decisions have been made.

OCBC is said to emerge as lead bidder for HSBC Indonesia assets

The fourth Amity Circle retreat was hosted by Temasek Foundation from Apr 8 to 10 in Hanoi.

Middle East-linked energy supply shocks put Asean Power Grid back in focus

Marco Beltgens, assistant vice-president of global franchising for the Asia-Pacific at Enterprise Mobility, with Charmain Kwee, group executive director of Eurokars Group.

Eurokars Group introduces rental car franchises Enterprise Rent-A-Car, National Car Rental, and Alamo to Singapore

Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
View More